The Journal of the National Cancer Institute recently published an article co-authored by Partner Kristen Rosati on the benefits and drawbacks of public-private partnerships (PPPs) in cancer research and the development of strategies to rapidly advance therapeutic innovations.

With Kristen’s unique legal insight complementing the perspectives of researchers and oncologists, the article examined opportunities for collaboration between government agencies, research institutions, universities, and pharmaceutical companies.

The article comes after Kristen was on the planning committee for and participated in a 2023 workshop on the same topic held by the National Cancer Policy Forum and the Forum on Drug Discovery, Development, and Translation

Considered one of the nation’s leading “Big Data” and HIPAA compliance attorneys, Kristen has deep experience in data governance and strategy, data sharing for research and innovation, and biobanking and genomic privacy.  Kristen is a past President of the American Health Law Association and has received numerous accolades for her work, including a recent recognition by Super Lawyers as one of the top 25 women attorneys in Arizona.

Read the full article and learn more about Kristen Rosati.